Last news
Mosaic Announces Quarterly Dividend of $0.21 Per Share
The Mosaic Company (NYSE:MOS) announced today that its Board of Directors declared a quarterly dividend of $0.21 per share on the Company's common stock. The dividend will be paid on December 19, 2024, to stockholders of record at the close of business on December 5, 2024.
Epique Realty Breaks New Ground in New Jersey With Bold Expansion and Premier Leadership
New State Broker Jeanne Borgers says, "Together we'll set a new standard for excellence in New Jersey."
374Water Releases Third Quarter 2024 Results and Provides Business Update
New Management Team Advances AirSCWO Technology, Operational in City of Orlando
Tecogen Announces Third Quarter 2024 Results
Tecogen Inc. (OTCQX:TGEN), a leading manufacturer of clean energy products, reported revenues of $5.63 million and net loss of $0.93 million for the quarter ended September 30, 2024 compared to revenues of $7.11 million, and a net loss of $0.48 million in 2023. We used $117 thousand in cash from operations and $839 thousand in property plant and equipment during the nine months ended September 30, 2024. Our cash balance was $1.28 million at September 30, 2024, which reflects $1.0 million of additional funding provided by related parties in the three months ended September 30, 2024.
Chronosphere Improves the Lives of On-Call Engineers with Powerful Observability Platform Functionalities
New Chronosphere Differential Diagnosis (DDx) Quickly Helps Identify the Root Cause of Application Issues in Minutes vs Hours
AI Meets Bollywood: 3 Body Labs Partners with Bollywood for Animated Film Revolution
Silicon Valley-based AI tech company, 3 Body Labs, has teamed up with leading Bollywood producers and distributors to bring animation to Bollywood films. 3 Body Labs has entered a strategic collaboration with APC Partners Limited and their Indian multimedia partner, Global One Enterprises Pvt. Ltd., founded by industry leader Siddharth Srivastava. This partnership is poised to produce Bollywood’s first anime films, marking a revolutionary moment in Indian cinema.
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United States
Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics
Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today that the European Patent Office intends to grant the Company a patent covering biodegradable polymeric nanoparticles created for carrying therapeutic and targeting agents. With particular utility in cancer therapies, this innovative platform is designed to enhance the delivery of therapeutic antibodies and peptides, which are often limited by enzymatic degradation and poor systemic circulation.
Tenon Medical Reports Third Quarter 2024 Financial Results
~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~~ Published Interim Analysis from MAINSAIL™ Study; Post-Market Study Supports the Safety and Efficacy of the Catamaran SI Joint Fusion System® Including Radiographic Proof of Fusion ~~ Initial Clinical Procedures Completed with New Catamaran SE Platform ~~ Granted Issuance of Three U.S. Patents ~~ Received Net Proceeds of ~$9.6 Million from Equity Financing Transactions ~
Urgently to Present at the Virtual Investor Summit Microcap Forum
Urgent.ly, Inc. (Nasdaq:ULY) ("Urgently"), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today announced that management will present virtually in the Investor Summit Microcap Forum on Thursday, November 21, 2024. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
Nano One Reports Q3 2024 Results and Provides Update
Q3 2024 Results and Subsequent Events - Highlights and Headlines:
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event
NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
Restricted Property Trust Achieve Major Court Victory Against IRS Over Restricted Property Trust Tax Structure
Court awards full attorney fees after Mann Construction, an RPT, LLC client, prevails in dispute over IRS penalty related to Restricted Property Trust transactions.
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
- Dermata nears completion of enrollment in its DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial -- Dermata continues discussions with potential botulinum toxin partners for DMT410 -- Raised $5.1 million in gross proceeds from financings completed in 3Q 2024 -
Builders, Craftsmen and Innovators Unite: Build Show LIVE Sparks a Movement in Building Science
Build Show LIVE, the brand-new tradeshow held last week in the heart of Austin, was the launch of a transformative movement, bringing together passionate builders, remodelers, architects and manufacturers from 47 states and nine countries, who are committed to elevating the future of residential construction.
Flutter Entertainment PLC Announces Launch of Share Buyback Program
Flutter Entertainment announces launch of first tranche of share repurchase program
New Report Commissioned by Digitunity Offers Essential Guide for Nonprofits Engaging in Digital Equity Evaluation
Based on real-world experience of 22 organizations, the study provides insights and tools for engaging stakeholders and securing funding.
Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
DehydraTECH clinical test article manufacturing has been completed
Gryphon Digital Mining, Inc. Reports Third Quarter 2024 Financial Results
Gryphon Digital Mining, Inc. (Nasdaq:GRYP) ("Gryphon," the "Company," "we," "our," and "us"), a bitcoin mining company that is focused on becoming the leader in low-cost, efficient operations, today reported financial results for its quarter ended September 30, 2024.
Zedge Marketplace Introduces Major Website Updates
Users Can Now Access More Zedge Content and Get Increased Value from Zedge Credit Purchases Made on the WebsiteModernized user interface mirrors mobile app
ParkerVision Reports Third Quarter 2024 Results
ParkerVision, Inc. (OTCQB:PRKR) ("ParkerVision" or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for the three and nine months ended September 30, 2024.
Commencement Bancorp, Inc. (CBWA) Announces 2024 Third Quarter Earnings
2024 Third Quarter Financial Highlights:Net income was $959,000 compared to $776,000 for the second quarter of 2024.Deposits increased $32.7 million, or 6.1%, from the second quarter of 2024. Annualized growth of 9.3%.Loans receivable increased $1.5 million, or 0.3%, from the second quarter of 2024. Annualized growth of 7.0%.Nonperforming assets to total assets decreased to 0.00% compared to 0.08% for the second quarter of 2024.Tangible book value per share increased to $13.45 compared to $12.52 for the second quarter of 2024.Capital ratios remained well above regulatory requirements.
Gaucho Holdings Initiates Chapter 11 Reorganization To Protect Core Assets
Strategic Filing Aims to Protect Operational Continuity for the Benefit of Stockholders
Liberty Helps Australians Book Their Next Holidays Sooner
Australians continue to prioritise travel and Liberty has personal loan solutions to help move their holiday plans forward.
Aehr Test Systems to Participate in the Craig-Hallum Alpha Select Conference in New York on November 19, 2024
(NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it will participate in the Craig-Hallum 15th Annual Alpha Select Conference taking place on November 19, 2024 at the Sheraton New York Times Square Hotel. President and CEO Gayn Erickson and CFO Chris Siu will be hosting meetings with institutional investors throughout the day.
Pure Cycle Announces Financial Results For the Year Ended August 31, 2024
Pure Cycle Corporation (NASDAQ Capital Market:PCYO) announced its financial results for the year ended August 31, 2024. Pure Cycle reported $11.6 million of net income for the year ended August 31, 2024, which is a 147% increase compared to 2023, and marks our seventh consecutive year and twenty-first consecutive fiscal quarter with positive net income. Pure Cycle reported $0.48 of earnings per fully diluted common shares, which is up from $0.19 in 2023, a 153% increase. We recognized a 135% increase in lot sales revenue for the year ended August 31, 2024 compared to 2023, due to an increase in our development activity. Pure Cycle continues to develop its Sky Ranch Master Planned Community, and as of August 31, 2024, we are actively working on Phases 2A, 2B and 2C. Phase 2A and 2B are substantially completed with finished lots delivered to homebuilders. We expect home builders to be able to begin construction in Phase 2C during fiscal 2025 and to start home building in Phase 2D in fiscal 2026.
Dalet and Caretta Research Publish "Future of Newsroom Workflows" Report
Insights Reveal the Need for News Organizations to Transform Operations to Thrive in a Rapidly Changing Landscape
ANGLE presents two posters at EACR
PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCETwo posters highlight the importance of epitope-independent CTC enrichment and molecular characterisation of CTCs
Jaguar Health Reports Third Quarter 2024 Financial Results
The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 million and 11% versus net Q3 2023 revenue of $2.8 millionJaguar reported significant results in breast cancer patients in its phase 3 OnTarget trial for its cancer supportive care drug crofelemer; results in breast cancer patients accepted for poster presentation on December 11, 2024 at the San Antonio Breast Cancer Symposium (SABCS)Jaguar initiated commercial launch in October 2024 for Gelclair®, the company's third prescription product, in alignment with Jaguar's focus on cancer supportive careJaguar is initiating two Phase 2 trials in Q4, 2024 and supporting multiple investigator-initiated proof-of-concept studies ("IIT") of crofelemer for the rare and orphan disease indications of microvillus inclusion disease (MVID) and short bowel syndrome (SBS) with intestinal failure in the US, EU, and Middle East/North Africa (MENA) regions; results of IITs expected by the end of 2024 and throughout 2025REMINDER: Jaguar to host investor webcast Wednesday, November 13th at 8:30 a.m. Eastern regarding Q3 2024 financials and company updates; Click here to register for webcast
SRH Total Return Fund, Inc. Increases Its Quarterly Distribution by 20% This Is the Fourth Consecutive Annual Increase
SRH Total Return Fund, Inc. (NYSE:STEW) (the "Fund") is pleased to announce a 20% increase in the Fund's quarterly distribution to $0.165 per share beginning in January 2025, payable on the date noted below. This is the fourth consecutive annual increase of the Fund's managed distribution. The distribution has been increased by 12.8% annually over the last four years. This distribution is being paid as part of the Fund's managed distribution program, under which the Fund intends to make per share distributions of $0.165 per quarter, or approximately $0.66 per year, to common stockholders. As of market close on November 8, 2024, the distribution (on an annualized basis) amounts to approximately 4.07% of the Fund's market price and 3.13% of its net asset value ("NAV"). The January 2025 quarterly distribution will be payable in cash to stockholders of record per the following critical dates:
Gladstone Capital Corporation Reports Financial Results for its Fourth Quarter and Fiscal Year Ended September 30, 2024
Gladstone Capital Corporation (Nasdaq:GLAD) (the "Company") today announced earnings for its fourth quarter and fiscal year ended September 30, 2024. Please read the Company's Annual Report on Form 10-K filed today with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website at www.sec.gov and the Investors section of the Company's website at www.GladstoneCapital.com.
SXG's Close Spaced Drilling at Rising Sun Confirms Continuity Includes 1.3 m @ 52.6 g/t Gold from 730.0 m
Mawson Gold Limited ("Mawson" or the "Company") (TSXV:MAW)(Frankfurt:MXR)(PINKSHEETS:MWSNF) announces Southern Cross Gold Ltd. ("Southern Cross Gold" or "SXG") has released results from five navigational diamond drill holes (SDDSC050W1, 050W2, 092W1, 092W2 and 092W3) at the Rising Sun prospect, at the 100%-owned Sunday Creek Gold-Antimony Project in Victoria (Figure 5).